Edinburgh Molecular Imaging

Edinburgh Molecular Imaging, a developer of optical molecular imaging technology based in Scotland (UK). EM Imaging was founded in 2014 by a team of experienced scientists and clinicians. Together, they have raised over £15 million in non-dilutive funding from the Wellcome Trust, EPSRC, and MRC to develop a unique series of SMART Agents for real-time molecular imaging to diagnose various disease states. The EM Imaging team has decades of successful track record in imaging agent discovery and development, with expertise spanning medicinal chemistry, biochemistry, cell biology, and direct clinical knowledge. The team also possesses extensive expertise in the clinical development, approval, and reimbursement of molecular imaging agents.